Type of content created: Blog post

  • Sort by
  • company

Whey protein is rapidly becoming a popular ingredient in clinical applications, thanks to its full complement of essential amino acids as well as several other bioactive constituents that together support treatment regimes for a number of common conditions, including sarcopenia, obesity and malnutrition, post-illness recovery. Such far-reaching potential is seeing rising global demand for whey protein in clinical nutrition, heading for USD 1.5 billion in sales by 2023.

Today, a wide variety of ingredients may appear on the label of infant formulas – a label mothers need to use to determine which product is right for their precious offspring. Alpha-lactalbumin, whey protein hydrolysates, OPN, phospholipids and MFGM are just some of the ingredients being highlighted, giving consumers plenty more to ponder over.

The prevalence of Type 2 diabetes has increased markedly over the last few decades, bringing with it a long list of complications including cardiovascular disease, cancer, damage to the nervous system, eyes and kidneys, cognitive function and heightened risk of dementia. Naturally, the diagnosis impacts on quality of life, and the disease comprises a growing economic burden for society.

Once a feed sample has been collected properly, it can be analyzed for nutrients. Most commercial laboratories offer standard feed tests for forages, grains or total mixed rations (TMRs). Analyzing feeds for moisture, protein and energy is recommended when designing diets for beef cattle.